Medmen Enterprises Class Stock Probability Of Bankruptcy
| MMNFFDelisted Stock | USD 0.0001 0.00 0.00% |
Medmen |
Medmen Enterprises Class OTC Stock chance of financial distress Analysis
Medmen Enterprises' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Medmen Enterprises Probability Of Bankruptcy | Over 100% |
Most of Medmen Enterprises' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medmen Enterprises Class is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Medmen Enterprises probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Medmen Enterprises odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Medmen Enterprises Class financial health.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
CompetitionBased on the latest financial disclosure, Medmen Enterprises Class has a Probability Of Bankruptcy of 100%. This is 131.0% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The probability of bankruptcy for all United States stocks is 151.07% lower than that of the firm.
Medmen Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medmen Enterprises' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Medmen Enterprises could also be used in its relative valuation, which is a method of valuing Medmen Enterprises by comparing valuation metrics of similar companies.Medmen Enterprises is currently under evaluation in probability of bankruptcy category among its peers.
Medmen Fundamentals
| Return On Asset | -0.0522 | |||
| Profit Margin | (1.04) % | |||
| Operating Margin | (0.24) % | |||
| Current Valuation | 390.25 M | |||
| Shares Outstanding | 1.3 B | |||
| Shares Owned By Insiders | 10.98 % | |||
| Shares Owned By Institutions | 2.97 % | |||
| Price To Book | 0.25 X | |||
| Price To Sales | 0.26 X | |||
| Revenue | 140.81 M | |||
| Gross Profit | 69.73 M | |||
| EBITDA | (106.73 M) | |||
| Net Income | (195.19 M) | |||
| Cash And Equivalents | 13.53 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 206.38 M | |||
| Debt To Equity | 7.54 % | |||
| Current Ratio | 0.50 X | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (62.53 M) | |||
| Earnings Per Share | (0.14) X | |||
| Target Price | 0.32 | |||
| Number Of Employees | 428 | |||
| Beta | 1.93 | |||
| Market Capitalization | 36.33 M | |||
| Total Asset | 323.22 M | |||
| Net Asset | 323.22 M |
About Medmen Enterprises Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medmen Enterprises Class's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medmen Enterprises using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medmen Enterprises Class based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in census. Note that the Medmen Enterprises Class information on this page should be used as a complementary analysis to other Medmen Enterprises' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Medmen OTC Stock
If you are still planning to invest in Medmen Enterprises Class check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medmen Enterprises' history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |